Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GGT1 | P19440 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 4/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.38 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39257 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL15637714 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL4992798 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL5825896 | 1.00 | CA2 (0.45) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL5688872 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL4998356 | 0.97 | CA2 (0.44) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| Ammonia Solution, Strong SCHEMBL8761546 | 0.97 | TDP1 (0.48) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| SCHEMBL6231707 | 0.95 | CA2 (0.42) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| Ammonia Solution, Strong SCHEMBL8620341 | 0.95 | TDP1 (0.46) | CA2CA4TDP1SMN1; SMN2GGT1 | |
| Ammonia Solution, Strong SCHEMBL7104814 | 0.95 | TDP1 (0.46) | CA2CA4TDP1SMN1; SMN2GGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 586 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297194-A1 | CLEANING METHOD OF SEMICONDUCTOR DEVICE, CLEANING APPARATUS OF SEMICONDUCTOR DEVICE AND SEMICONDUCTOR CLEANING COMPOSITION | DAXIN MATERIALS CORPORATION (TW) | 2025-09-25 | — | — | US | claimed |
| EP-4621829-A1 | CLEANING METHOD OF SEMICONDUCTOR DEVICE, CLEANING APPARATUS OF SEMICONDUCTOR DEVICE AND SEMICONDUCTOR CLEANING COMPOSITION | Daxin Materials Corporation (TW) | 2025-09-24 | — | — | EP | claimed |
| EP-4591613-A1 | SYSTEMS AND METHODS FOR PROVIDING A LOW DELAY SERVICE IN A WIRELESS LOCAL AREA NETWORK (WLAN) | Huawei Technologies Co., Ltd. (CN) | 2025-07-30 | — | — | EP | claimed |
| US-12349132-B2 | Systems and methods for providing a low delay service in a wireless local area network (WLAN) | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2025-07-01 | — | — | US | claimed |
| CN-119948931-A | System and method for providing low delay services in a Wireless Local Area Network (WLAN) | 华为技术有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20250101344-A1 | PHOSPHONATE-FREE CHELATING AGENTS AND METHODS FOR FABRIC CARE | THE PROCTER & GAMBLE COMPANY | 2025-03-27 | — | — | US | claimed |
| WO-2025064740-A1 | PHOSPHONATE-FREE CHELATING AGENTS AND METHODS FOR FABRIC CARE | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-27 | — | — | WO | claimed |
| CN-118830064-A | Treatment fluid and method of use thereof | 日本化药株式会社 | 2024-10-22 | — | — | CN | claimed |
| US-20240236976-A9 | SYSTEMS AND METHODS FOR PROVIDING A LOW DELAY SERVICE IN A WIRELESS LOCAL AREA NETWORK (WLAN) | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-07-11 | — | — | US | claimed |
| WO-2024082968-A1 | SYSTEMS AND METHODS FOR PROVIDING A LOW DELAY SERVICE IN A WIRELESS LOCAL AREA NETWORK (WLAN) | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-04-25 | — | — | WO | claimed |
| EP-0770055-A1 | A PROCESS FOR OBTAINING [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID FROM A SALT SOLUTION OF SUCH ACID AND L-ASPARTIC ACID | ALBEMARLE CORPORATION (US) | 1997-05-02 | — | — | EP | claimed |
| US-5587512-A | Process for obtaining [S,S]-ethylenediamine-n,n'-disuccinic acid from a salt solution of such acid and l-aspartic acid | ALBEMARLE CORPORATION (US) | 1996-12-24 | — | — | US | claimed |
| US-5554791-A | Process for producing [S,S]-ethylenediamine-N,N'-disuccinic acid | ALBEMARLE CORPORATION (US) | 1996-09-10 | — | — | US | claimed |
| US-5550285-A | Method for producing calcium salts of [S,S]-ethylenediamine-N,N'-disuccinic acid | ALBEMARLE CORPORATION | 1996-08-27 | — | — | US | claimed |
| EP-0694528-A2 | Alkylenediamine-N,N'-disuccinic acid iron (III) complex salts and process for production thereof | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1996-01-31 | — | — | EP | claimed |
| WO-1996001804-A1 | METHOD FOR PRODUCING CALCIUM SALTS OF [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | claimed |
| WO-1996001803-A1 | A PROCESS FOR PRODUCING [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | claimed |
| WO-1996001802-A1 | A PROCESS FOR OBTAINING [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID FROM A SALT SOLUTION OF SUCH ACID AND L-ASPARTIC ACID | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | claimed |
| WO-1996001801-A1 | A METHOD FOR PRODUCING [S,S]-ETHYLENEDIAMINE-N,N'-DISUCCINIC ACID FROM ITS CALCIUM SALT | ALBEMARLE CORPORATION (US) | 1996-01-25 | — | — | WO | claimed |
| US-5466867-A | Method for producing [S,S]-ethylenediamine-N,N'-disuccinic acid from its calcium salt | ALBEMARLE CORPORATION (US) | 1995-11-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101344-A1 | PHOSPHONATE-FREE CHELATING AGENTS AND METHODS FOR FABRIC CARE | C9, C5, C3AR1 | CA2 1195/4885CA4 252/4885TDP1 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.